Nxera

Nxera Pharma (formerly Sosei Heptares) is a technology-driven biopharmaceutical company committed to developing new specialty medicines to improve the lives of patients with unmet needs in Japan and globally. In addition to several products commercialized in Japan, we are advancing a broad pipeline of over 30 active projects internally, ranging from discovery to late-stage clinical phases, while collaborating with leading pharmaceutical and biotechnology companies. The pipeline focuses on addressing key unmet needs in some of the fastest-growing medical fields, including neurology, gastroenterology and immunology, metabolic disorders, and rare diseases, leveraging the power of our unique and industry-leading GPCR-targeted structure-based drug discovery NxWave™ platform to provide a sustainable source of best-in-class or first-in-class drug candidates.